Microrna-21 Negatively Regulates Cdc25A and Cell Cycle Progression in Colon Cancer Cells.

Peng Wang,Fangdong Zou,Xiaodong Zhang,Hua Li,Austin Dulak,Robert J. Tomko,John S. Lazo,Zhenghe Wang,Lin Zhang,Jian Yu
DOI: https://doi.org/10.1158/0008-5472.can-09-1996
IF: 11.2
2009-01-01
Cancer Research
Abstract:AbstractmicroRNAs (miRNA) are small noncoding RNAs that participate in diverse biological processes by suppressing target gene expression. Altered expression of miR-21 has been reported in cancer. To gain insights into its potential role in tumorigenesis, we generated miR-21 knockout colon cancer cells through gene targeting. Unbiased microarray analysis combined with bioinformatics identified cell cycle regulator Cdc25A as a miR-21 target. miR-21 suppressed Cdc25A expression through a defined sequence in its 3′-untranslated region. We found that miR-21 is induced by serum starvation and DNA damage, negatively regulates G1-S transition, and participates in DNA damage–induced G2-M checkpoint through down-regulation of Cdc25A. In contrast, miR-21 deficiency did not affect apoptosis induced by a variety of commonly used anticancer agents or cell proliferation under normal cell culture conditions. Furthermore, miR-21 was found to be underexpressed in a subset of Cdc25A-overexpressing colon cancers. Our data show a role of miR-21 in modulating cell cycle progression following stress, providing a novel mechanism of Cdc25A regulation and a potential explanation of miR-21 in tumorigenesis. [Cancer Res 2009;69(20):8157–65]
What problem does this paper attempt to address?